You just read:

Janssen Submits Two Applications To FDA Seeking Approval Of SIMPONI ARIA® (golimumab) For The Treatment Of Active Psoriatic Arthritis And Active Ankylosing Spondylitis

News provided by

Janssen Biotech, Inc.

Dec 20, 2016, 16:45 ET